header("Access-Control-Allow-Origin: *"); ?>
therapeuticpublished patents
oncologypublished patents
research tools
diagnosticpublished patents
Welcome to our Technology Offers website You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.
Diagnostic
Research
Therapeutic
Flow Cytometry
Immunocytochemistry
Immunoprecipitation
In vivo studies
Western Blot
Cardiovascular Diseases
Central Nervous System
Dermatology
Ear nose throat disease
Gastrointestinal Diseases
Genetic Disorders
Genito Urinary System
Hematological Disorders
Immunology
Musculoskeletal
Nutritional disorder
Oncology
Ophtalmology
Respiratory Disease
Women health
Others
Infectious diseases
The Bd37 is an erythrocyte binding protein anchored at the surface of the parasite Babesia divergens. B. divergens is an Apicomplexa parasite, mostly […]
We can offer and produce selective AEBS lignads for research purpose only.These compounds are potent inducers of breast cancer cell differentiation […]
Expression vectors encoding human cellular fibronectin variants harboring the alternatively spliced Extra Domains B and/or A (or neither) ; […]
Comprehensive inventory of 5,000 rare diseases, indexed with ICD10, OMIM, genes (HGNC nomenclature), swissprot, genatlas, class of prevalence, class […]
Directory of 5,000 ongoing academic research projects funded at national or European level in 36 countries, classified by disease and health product […]
[…]
This transgenic mice model contains large human genomic DNA sequence carrying the DMPK gene with […]
Transgenic mouse model carrying the myotonic dystrophy type 1 (DM1) locus (45kb of human sequences) […]
Mouse monoclonal antibody directed against mouse CCL5. Antibody was produced by immunising CCL5 […]
The cholangiocarcinoma cell line SB1-JP4 is syngeneic to C57Bl/6 mice.It was derived from a […]
When undifferentiated, invasive neoplastic cell lines are treated with an optimal time / […]